Ophthalmic Pharmaceutical Drugs Market Projected to Grow at a Steady Pace During 2022-2028

Stratview Research delivers key insights into the global Ophthalmic Pharmaceutical Drugs Market. According to Stratview Research, the market is segmented By Type (Prescription Drugs, OTC Drugs), By Class (Antiallergy, Anti-VEGF Agents, Anti-inflammatory [Nonsteroidal Drugs, Steroidal Drugs], Antiglaucoma, Others), By Disease (Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Retinal Disorders  [Macular Degeneration, Diabetic Retinopathy, Others], Uveitis, Others), By Dosage (Gels, Eye Solutions, Capsules & Tablets, Eye Drops, Ointments), and Region - COVID-19 Impact Analysis and Forecast to 2028.

Why invest in this report?

The report provides an in-depth analysis of the Ophthalmic Pharmaceutical Drugs Market including critical market information and valuable insights which are of high value to the companies, enabling them to know and understand several other opportunities in the market. The report also aims at answering the following key questions –

• What is the current and future potential of Ophthalmic Pharmaceutical Drugs Market?
• How will the COVID-19 pandemic impact the market?
• How are other crucial market factors changing the market dynamics?
• When is the recovery expected from the pandemic?
• Which segments offer high-growth opportunities in the long run?
• How fierce is the market competition?
• What are the key emerging trends?
• What are the strategic growth opportunities and key success factors?

To get detailed insights about this study, click here: https://www.stratviewresearch.com/Request-Sample/2285/Ophthalmic-Pharmaceutical-Drugs-Market.html#form

Key Players:

Key players operating in the ophthalmic pharmaceutical drugs market are-

• AbbVie Inc. (Allergan plc) (US)
• Alcon Inc. (Switzerland)
• Bausch & Lomb Incorporated (Canada)
• F. Hoffmann-La Roche Ltd (Genentech, Inc.) (Switzerland)
• Novartis AG (Switzerland)
• Pfizer Inc. (US)
• Regeneron Pharmaceuticals Inc.
• Santen Pharmaceutical Co., Ltd. (Japan)
• Sun Pharmaceutical Industries Ltd. (India)
• Teva Pharmaceutical Industries Ltd. (Actavis Generics) (Israel).

Segment Analysis

By Type

The market has been segmented into (Prescription Drugs, and OTC Drugs). The Prescription Drugs segment accounted for a revenue share of nearly 60% in 2021.

By Class Type

The ophthalmic pharmaceutical drugs market is classified into antiallergy, anti-VEGF agents, anti-inflammatory antiglaucoma, and others. The Anti-VEGF Agents segment accounted for a revenue share of more than 31.0% in 2021 and is estimated to register a healthy CAGR during the forecast timeline. This is mainly attributed to the growing adoption rate and large presence of global industry players with extensive product portfolios. The segment growth is propelled by robust commercial performances of Avastin (bevacizumab), Lucentis (ranibizumab), and Macugen (pegaptanib), which bolsters the segment growth.

By Disease Type

The market has been segmented into (Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Retinal Disorders [Macular Degeneration, Diabetic Retinopathy, and Others], Uveitis, and Others). The Retinal Disorders segment accounted for a revenue share of more than 33.0% in 2021.

By Dosage Type

The market has been segmented into (Gels, Eye Solutions, Capsules & Tablets, Eye Drops, and Ointments). The Eye Drops segment accounted for a revenue share of more than 34.0% in 2021.

By Region

The North American market accounted for a revenue share of more than 39.5% in 2021 and is expected to grow at a substantial CAGR in the following years. This is mainly ascribed to a surge in the number of cataract surgeries performed, high consumer awareness, the presence of excellent healthcare infrastructure, the large presence of a majority of major players, and a rise in government intervention for the prevention of visual impairment, thereby proliferating the regional market growth.

Competitive Benchmarking

Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Share your requirements at -

Stratview Research

E-mail: sales@stratviewresearch.com

Direct: +1-313-307-4176

About Stratview Research:

Stratview Research is a credible source for gaining market intelligence to exponentially accelerate the user’s business. Our team of veterans and analysts have extensive experience in executing custom research projects for mid-sized to fortune companies, in the areas of Market Assessment, Opportunity Screening, Competitive Intelligence, Due Diligence, Target Screening, Market Entry Strategy, and more.

Article source: https://article-realm.com/article/Finance/30340-Ophthalmic-Pharmaceutical-Drugs-Market-Projected-to-Grow-at-a-Steady-Pace-During-2022-2028.html